Active, Not Recruiting
Study of Elranatamab for Relapsed or Refractory Myeloma in Patients Previously Exposed to Three-drug Classes
NCT06282978
- Conditions
- Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +13 more
- Locations
-
- Hospital Clínico Universitario de Santiago ~ CHUS Santiago de Compostela, A Coruña, Spain
- Hospital Son Llàtzer Palma de Mallorca, Balearic Islands, Spain
- Institut Catala d'Oncologia (ICO) Badalona - Hospital Universitari Germans Trias i Pujol Badalona, Barcelona, Spain
- Hospital Universitario Marqués de Valdecilla Santander, Cantabria, Spain